Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Intersection of Patient Experience and Safety

As National Director of Patient Experience at Compass One Healthcare and its subsidiary, Crothall Healthcare, Grant Randall knows the importance of patient experience and satisfaction. Factors such as the perception of safety in a healthcare environment create the reality – a hospital can do everything it can to make a patient safe, but customer satisfaction…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
The Intersection of Patient Experience and Safety

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

As National Director of Patient Experience at Compass One Healthcare and its subsidiary, Crothall Healthcare, Grant Randall knows the importance of patient experience and satisfaction. Factors such as the perception of safety in a healthcare environment create the reality – a hospital can do everything it can to make a patient safe, but customer satisfaction scores will go down if the experience doesn’t match reality.

Randall shared his experiences on some surprising ways that made all the difference in patient satisfaction.

The patient experience became an important consideration for healthcare organizations as value-based purchasing became a reimbursement KPI for hospitals through HCAHPS and patient satisfaction scores. And, beyond the CMS and reimbursement portions, Randall said it’s really about doing the right thing for patients.

“How can we bring them into our hospital and make them comfortable?,” Randall said. “And how can we show them empathy through the great clinical care that we’re giving?”

Safety, and a patient’s perception of safety, isn’t a new concern for healthcare organizations. Still, the pandemic did spotlight the importance of ensuring patients feel the hospital environment is safe.

And, while hospitals may be taking all the right safety precautions and instituting every protocol to protect patients and staff from the coronavirus, seeing is believing. And that is one area where Randall said Crothall Healthcare experienced a sharp rise in patient satisfaction scores.

“We had partnered with Surfacide several years ago with their UV-C technology,” Randall said. “We were using it almost specifically in discharge rooms and all ORs. That was already pretty standard. We started seeing the data come back on the coronavirus, and we said, if we can get this in every single room, let’s get it in every single room.”

One interesting and unintended benefit of utilizing the Surfacide Helios System was the patient reaction. They were fascinated by the units and excited that Crothall took the extra steps to ensure patient safety.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS's ACCESS payment model, fully active as of July 2026, pays companies $90 to $420 per Medicare beneficiary per year for technology-supported chronic care tied to outcomes, according to HFMA. The model also requires participants to connect through CMS-designated interoperability networks, and more tech companies than traditional providers have signed on so far.

  • 01CMS ACCESS model provides annual payments of $90 to $420 per Medicare beneficiary for chronic care supported by technology.
  • 02Payments in the ACCESS model range from $90 to $420 per beneficiary per year depending on whether specified outcome targets are met.
  • 03The initiative aims to promote the integration of technology in chronic care management.

Sep 10, 2026

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512